Showing 1 - 7 results of 7 for search 'Barbara A. Wetmore', query time: 0.03s Refine Results
  1. 1
    Advancing understanding of human variability through toxicokinetic modeling, in vitro-in vivo extrapolation, and new approach methodologies

    Advancing understanding of human variability through toxicokinetic modeling, in vitro-in vivo extrapolation, and new approach methodologies by Anna Kreutz, Xiaoqing Chang, Helena T. Hogberg, Barbara A. Wetmore

    Published 2024-11-01
    Get full text
    Article
  2. 2
    Closing the Gaps in Understanding PFAS Toxicology and Metabolism

    Closing the Gaps in Understanding PFAS Toxicology and Metabolism by Denise K. MacMillan, Barbara A. Wetmore, Subham Dasgupta, William S. Baldwin

    Published 2024-12-01
    Get full text
    Article
  3. 3
    Category-Based Toxicokinetic Evaluations of Data-Poor Per- and Polyfluoroalkyl Substances (PFAS) using Gas Chromatography Coupled with Mass Spectrometry

    Category-Based Toxicokinetic Evaluations of Data-Poor Per- and Polyfluoroalkyl Substances (PFAS) using Gas Chromatography Coupled with Mass Spectrometry by Anna Kreutz, Matthew S. Clifton, W. Matthew Henderson, Marci G. Smeltz, Matthew Phillips, John F. Wambaugh, Barbara A. Wetmore

    Published 2023-05-01
    Get full text
    Article
  4. 4
    In Vitro Hepatic Clearance Evaluations of Per- and Polyfluoroalkyl Substances (PFAS) across Multiple Structural Categories

    In Vitro Hepatic Clearance Evaluations of Per- and Polyfluoroalkyl Substances (PFAS) across Multiple Structural Categories by David M. Crizer, Julie R. Rice, Marci G. Smeltz, Katelyn S. Lavrich, Krishna Ravindra, John F. Wambaugh, Michael DeVito, Barbara A. Wetmore

    Published 2024-09-01
    Get full text
    Article
  5. 5
    Dose Response, Dosimetric, and Metabolic Evaluations of Replacement PFAS Perfluoro-(2,5,8-trimethyl-3,6,9-trioxadodecanoic) Acid (HFPO-TeA)

    Dose Response, Dosimetric, and Metabolic Evaluations of Replacement PFAS Perfluoro-(2,5,8-trimethyl-3,6,9-trioxadodecanoic) Acid (HFPO-TeA) by Aero Renyer, Krishna Ravindra, Barbara A. Wetmore, Jermaine L. Ford, Michael DeVito, Michael F. Hughes, Leah C. Wehmas, Denise K. MacMillan

    Published 2023-11-01
    Get full text
    Article
  6. 6
    A Comparison of In Vitro Points of Departure with Human Blood Levels for Per- and Polyfluoroalkyl Substances (PFAS)

    A Comparison of In Vitro Points of Departure with Human Blood Levels for Per- and Polyfluoroalkyl Substances (PFAS) by Richard S. Judson, Doris Smith, Michael DeVito, John F. Wambaugh, Barbara A. Wetmore, Katie Paul Friedman, Grace Patlewicz, Russell S. Thomas, Risa R. Sayre, Jennifer H. Olker, Sigmund Degitz, Stephanie Padilla, Joshua A. Harrill, Timothy Shafer, Kelly E. Carstens

    Published 2024-04-01
    Get full text
    Article
  7. 7
    IVIVE: Facilitating the Use of <i>In Vitro</i> Toxicity Data in Risk Assessment and Decision Making

    IVIVE: Facilitating the Use of <i>In Vitro</i> Toxicity Data in Risk Assessment and Decision Making by Xiaoqing Chang, Yu-Mei Tan, David G. Allen, Shannon Bell, Paul C. Brown, Lauren Browning, Patricia Ceger, Jeffery Gearhart, Pertti J. Hakkinen, Shruti V. Kabadi, Nicole C. Kleinstreuer, Annie Lumen, Joanna Matheson, Alicia Paini, Heather A. Pangburn, Elijah J. Petersen, Emily N. Reinke, Alexandre J. S. Ribeiro, Nisha Sipes, Lisa M. Sweeney, John F. Wambaugh, Ronald Wange, Barbara A. Wetmore, Moiz Mumtaz

    Published 2022-05-01
    Get full text
    Article

Search Tools: